aTyr Pharma, Inc.-aTyr Pharma's lung disease drug misses main goal in late-stage trial - Reportify

aTyr Pharma's lung disease drug misses main goal in late-stage trial

aTyr Pharma, Inc.(US:ATYR) Reuters·2025-09-15 11:55

药物临床试验结果 - 公司实验性药物在治疗肺结节病的后期研究中未能达到主要终点[1] - 该药物针对的适应症为一种称为肺结节病的肺部疾病[1]